Data back efficacy of inhaled insulin in diabetes care

Inhaled insulin was as effective as rapid acting analog insulin in improving A1C and fared better in reducing body weight, fasting plasma glucose and hypoglycemic events in type 1 diabetes patients, researchers reported at the ADA 74th Scientific Sessions. The treatment also outperformed placebo ...

Share

This news summary appeared in DiabetesPro SmartBrief on 06/18/2014
Click here to view the full issue.


View the original article:
Healio (free registration)

Want to see more news summaries?
Sign up for DiabetesPro SmartBrief

DiabetesPro SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news summaries like the one to the left
Sign up:
About SmartBrief
SmartBrief is the leading online publisher of targeted business news and information by industry. By combining technology and editorial expertise, SmartBrief filters thousands of sources daily to deliver the most relevant industry news in partnership with more than 180 trade associations, professional societies nonprofits and corporate entities